中文
 

Follow us 

Hot Topic
Market News
Events & Promo
Career Tips
Education News
Health & Life
BioQ Debuts at in‑cosmetics Global, Showcasing China's Advancing Strength in Ingredient Innovation
PRNewswire

BioQ Debuts at in‑cosmetics Global, Showcasing China's Advancing Strength in Ingredient Innovation

Publish date: 08 May 2026

Follow us

Stay updated on the job market

Popular Articles

公司立場同你唔同  打工仔如何自保?
公司立場同你唔同 打工仔如何自保?
香港中醫醫院舉辦「招聘日」 醫・教・研並重  招募中醫師、西醫等支援及行政人才加入中西醫協作平台
香港中醫醫院舉辦「招聘日」 醫・教・研並重 招募中醫師、西醫等支援及行政人才加入中西醫協作平台
【報稅2026】「綠色炸彈」來襲!填表流程、時間表+扣稅全攻略
【報稅2026】「綠色炸彈」來襲!填表流程、時間表+扣稅全攻略
「先問AI再問老闆」成職場新文化
「先問AI再問老闆」成職場新文化
公司要你借400萬?警惕求職借貸騙案
公司要你借400萬?警惕求職借貸騙案

PARIS, May 8, 2026 /PRNewswire/ -- BioQ, the biotechnology affiliate of Chinese skincare brand GUYU, made its first appearance as a raw-material supplier at in-cosmetics Global, held April 14–16, 2026, in Paris. Widely regarded as the most prestigious stage for cosmetic ingredients, the event admits only companies with proven independent R&D and production capabilities — placing BioQ alongside established giants. BioQ Senior Scientist Hou Sen presented three proprietary ingredients — demonstrating GUYU's capacity to independently develop and produce all its key raw materials.

BioQ - GUYU participates in in-cosmetics Global 2026
BioQ - GUYU participates in in-cosmetics Global 2026

AuroGlab is an advanced, high-purity glabridin derived from Glycyrrhiza glabra. Through proprietary melt-crystallization purification, BioQ has achieved 99% purity — among the highest reported in the industry. Its 28-nanometer encapsulation technology enhances transdermal absorption by 3.4 times, while targeted-delivery mechanisms improve precision in addressing melanocytes.

Ginsenoside CK is a rare, highly active ginseng metabolite. Using an AI-driven enzyme-screening system, BioQ achieved high-purity, industrial-scale output with concentrations over 7,000 times higher than natural sources. Efficacy studies show that CK engages with 22 anti-aging targets, outperforming several benchmark actives.[1]

Biomimetic Extracellular Vesicles (BEV) is inspired by four Nobel Prize winning discoveries. It represents the world-leading functional ingredient designed to precisely mimic human cellular structures. By delivering youthful signals directly to cells, BEV captures the benefits of exosome technology while avoiding the potential risks associated with natural exosomes. Its precise 18.7nm particle size allows it to penetrate the skin's surface non-invasively, reaching deep into the cellular level.

Through AI-guided functional programming, BEV combines an optimized ratio of gene-level active ingredients, such as miRNA, siRNA, NAD+, and PDRN, to significantly amplify its anti-aging effects. Laboratory tests show that BEV reduces aging cells by 64.08% within just eight hours.[2] Furthermore, after 24 hours, it restores the ATP energy levels of 58-year-old cells to 89% of the vitality found in 20-year-old cells.[3] Separately, it exhibits core activity levels 2.2 to 6.7 times higher than those of human-derived exosomes.

Currently protected by two core patents, this ingredient is a centerpiece of GUYU's leadership in the frontier of cellular anti-aging. As a key company involved in setting the Chinese national standards for this field, GUYU's development of BEV officially marks the beginning of the era of cellular-level precision skincare.

BioQ's debut at in-cosmetics Global signals that GUYU has become an upstream technology company capable of exporting proprietary raw materials to the global market, reflecting the growing influence of Chinese innovation in the beauty supply chain.

[1] Data source from the internal report of the brand laboratory

[2] Data sourced from SGS-CSTC Standards Technical Services Co., Ltd. (Guangzhou Branch) (Report No.: GZCPCH26000902-01CN). The results indicated a 64.08% reduction in the proportion of senescence-associated β-galactosidase (SA-β-gal) positive cells compared to the model group after 8-hour treatment with HME

[3] Data sourced from Shaanxi Boxi General Testing Technology Co., Ltd. (Report No.: G4431-2601075). The results demonstrated that treatment with HME for 24 hours increased ATP levels in subjects' fibroblasts by 111.9%, restoring them to 89% of the levels observed in fibroblasts from 20-year-old individuals.

Follow us

Stay updated on the job market

Popular Articles

公司立場同你唔同  打工仔如何自保?
公司立場同你唔同 打工仔如何自保?
香港中醫醫院舉辦「招聘日」 醫・教・研並重  招募中醫師、西醫等支援及行政人才加入中西醫協作平台
香港中醫醫院舉辦「招聘日」 醫・教・研並重 招募中醫師、西醫等支援及行政人才加入中西醫協作平台
【報稅2026】「綠色炸彈」來襲!填表流程、時間表+扣稅全攻略
【報稅2026】「綠色炸彈」來襲!填表流程、時間表+扣稅全攻略
「先問AI再問老闆」成職場新文化
「先問AI再問老闆」成職場新文化
公司要你借400萬?警惕求職借貸騙案
公司要你借400萬?警惕求職借貸騙案

Hottest Tags

#公司立場
#言論自由
#和平討論
#立場
#香港中醫醫院
#中醫院
#中醫師
#中醫醫院
#卞兆祥
#西醫
#香港中醫醫院招聘日
#報稅表

Contact Us
Notice
Back to Top
We use cookies to enhance your experience on our website. Please read and confirm your agreement to our Privacy Policy and Terms and Conditions before continue to browse our website. Read and Agreed